Factors Associated with Exercise-Induced Desaturation in Patients with Chronic Obstructive Pulmonary Disease

References

• DecramerM, JanssensW. Chronic obstructive pulmonary disease and comorbidities. Lancet Respir Med. 2013;1(1):73–83. doi:10.1016/S2213-2600(12)70060-724321806
   PubMed Web of Science ®Google Scholar
• FearyJR, RodriguesLC, SmithCJ, et al. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax. 2010;65(11):956–962. doi:10.1136/thx.2009.12808220871122
   PubMed Web of Science ®Google Scholar
• ManninoDM, DohertyDE, BuistAS. Global initiative on obstructive lung disease (GOLD) classification of lung disease and mortality: findings from the atherosclerosis risk in communities (ARIC) study. Respir Med. 2006;100(1):115–122. doi:10.1016/j.rmed.2005.03.03515893923
   PubMed Web of Science ®Google Scholar
• HurstJR, VestboJ, AnzuetoA, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138. doi:10.1056/NEJMoa090988320843247
   PubMed Web of Science ®Google Scholar
• Soler-Cataluna J, Martínez-García MÁ, Sánchez PR, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925–931. doi:10.1136/thx.2005.04052716055622
   PubMed Web of Science ®Google Scholar
• KimV, BendittJO, WiseRA, et al. Oxygen therapy in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008;5(4):513–518. doi:10.1513/pats.200708-124ET18453364
   PubMedGoogle Scholar
• NonoyamaML, BrooksD, GuyattGH, et al. Effect of oxygen on health quality of life in patients with chronic obstructive pulmonary disease with transient exertional hypoxemia. Am J Respir Crit Care Med. 2007;176(4):343–349. doi:10.1164/rccm.200702-308OC17446339
   PubMed Web of Science ®Google Scholar
• PanosRJ, EschenbacherW. Exertional desaturation in patients with chronic obstructive pulmonary disease. COPD. 2009;6(6):478–487. doi:10.3109/1541255090334149719938972
   PubMedGoogle Scholar
• TakigawaN, TadaA, SodaR, et al. Distance and oxygen desaturation in 6-min walk test predict prognosis in COPD patients. Respir Med. 2007;101(3):561–567. doi:10.1016/j.rmed.2006.06.01716899358
   PubMed Web of Science ®Google Scholar
• BeattyAL, SchillerNB, WhooleyMA. Six-minute walk test as a prognostic tool in stable coronary heart disease: data from the heart and soul study. Arch Intern Med. 2012;172(14):1096–1102. doi:10.1001/archinternmed.2012.219822710902
   PubMedGoogle Scholar
• GuazziM, Dickstein K, Vicenzi M, Arena R. Six-minute walk test and cardiopulmonary exercise testing in patients with chronic heart failure: a comparative analysis on clinical and prognostic insights. Circ Heart Fail. 2009;2(6):549–555.19919979
   PubMed Web of Science ®Google Scholar
• HsiehM-H, FangY-F, ChungF-T, et al. Distance-saturation product of the 6-minute walk test predicts mortality of patients with non-cystic fibrosis bronchiectasis. J Thorac Dis. 2017;9(9):3168. doi:10.21037/jtd.2017.08.5329221293
   PubMed Web of Science ®Google Scholar
• LettieriCJ, NathanSD, BrowningRF, et al. The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis. Respir Med. 2006;100(10):1734–1741. doi:10.1016/j.rmed.2006.02.00416545950
   PubMed Web of Science ®Google Scholar
• MiyamotoS, NagayaN, SatohT, et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension: comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2000;161(2):487–492. doi:10.1164/ajrccm.161.2.990601510673190
   PubMed Web of Science ®Google Scholar
• CamilloCA, LangerD, OsadnikC, et al. Survival after pulmonary rehabilitation in patients with COPD: impact of functional exercise capacity and its changes. Int J Chron Obstruct Pulmon Dis. 2016;11:2671. doi:10.2147/COPD.S11345027822029
   PubMed Web of Science ®Google Scholar
• WaatevikM, JohannessenA, Gomez RealF, et al. Oxygen desaturation in 6-min walk test is a risk factor for adverse outcomes in COPD. Eur Respir J. 2016;48(1):82–91. doi:10.1183/13993003.00975-201527076586
   PubMed Web of Science ®Google Scholar
• DuH, WonggomP, TongpethJ, et al. Six-minute walk test for assessing physical functional capacity in chronic heart failure. Curr Heart Fail Rep. 2017;14(3):158–166. doi:10.1007/s11897-017-0330-328421409
   PubMedGoogle Scholar
• ShaoSC, Chan-Y-Y, Kao YangY-H, et al. The Chang Gung research database—a multi-institutional electronic medical records database for real‐world epidemiological studies in Taiwan. Pharmacoepidemiol Drug Saf. 2019;28(5):593–600. doi:10.1002/pds.471330648314
   PubMed Web of Science ®Google Scholar
• TsaiM-S, LinM-H, LeeC-P, et al. Chang Gung research database: a multi-institutional database consisting of original medical records. Biomed J. 2017;40(5):263–269. doi:10.1016/j.bj.2017.08.00229179881
   PubMed Web of Science ®Google Scholar
• WedzichaJ. Domiciliary oxygen therapy services: clinical guidelines and advice for prescribers. Summary of a report of the Royal College of Physicians. J R Coll Physicians Lond. 1999;33(5):445–447.10624659
   PubMedGoogle Scholar
• GuptaR, RuppelGL, EspirituJRD. Exercise-induced oxygen desaturation during the 6-minute walk test. Med Sci. 2020;8(1):8. doi:10.3390/medsci8010008
   Google Scholar
• AndrianopoulosV, FranssenFME, PeetersJPI, et al. Exercise-induced oxygen desaturation in COPD patients without resting hypoxemia. Respir Physiol Neurobiol. 2014;190:40–46. doi:10.1016/j.resp.2013.10.00224121092
   PubMed Web of Science ®Google Scholar
• PerezT, DesléeG, BurgelPR, et al. Predictors in routine practice of 6-min walking distance and oxygen desaturation in patients with COPD: impact of comorbidities. Int J Chron Obstruct Pulmon Dis. 2019;14:1399. doi:10.2147/COPD.S18841231308646
   PubMed Web of Science ®Google Scholar
• KleinbaumDG, KupperLL, MorgensternH. Epidemiologic Research: Principles and Quantitative Methods. John Wiley & Sons; 1982.
   Google Scholar
• RothmanKJ, GreenlandS. Modern Epidemiology. 2nd ed. Philadelphia: Lippincott-Raven; 1998.
   Google Scholar
• TashkinDP, CelliB, SennS, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;359(15):1543–1554. doi:10.1056/NEJMoa080580018836213
   PubMed Web of Science ®Google Scholar
• AndrianopoulosV, CelliBR, FranssenFME, et al. Determinants of exercise-induced oxygen desaturation including pulmonary emphysema in COPD: results from the ECLIPSE study. Respir Med. 2016;119:87–95. doi:10.1016/j.rmed.2016.08.02327692154
   PubMed Web of Science ®Google Scholar
• BhattSP, WellsJM, KinneyGL, et al. β-Blockers are associated with a reduction in COPD exacerbations. Thorax. 2016;71(1):8–14. doi:10.1136/thoraxjnl-2015-20725126283710
   PubMed Web of Science ®Google Scholar
• SalpeterSR, OrmistonTM, SalpeterEE. Cardioselective beta‐blockers for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2005;4.
   Google Scholar
• DransfieldMT, McAllisterDA, AndersonJA, et al. β-blocker therapy and clinical outcomes in patients with moderate chronic obstructive pulmonary disease and heightened cardiovascular risk. An observational substudy of SUMMIT. Ann Am Thorac Soc. 2018;15(5):608–614. doi:10.1513/AnnalsATS.201708-626OC29406772
   PubMed Web of Science ®Google Scholar
• YoshihisaA, TakiguchiM, ShimizuT, et al. Cardiovascular function and prognosis of patients with heart failure coexistent with chronic obstructive pulmonary disease. J Cardiol. 2014;64(4):256–264. doi:10.1016/j.jjcc.2014.02.00324674751
   PubMed Web of Science ®Google Scholar
• DurheimMT, Cyr DD, Lopes RD, et al. Chronic obstructive pulmonary disease in patients with atrial fibrillation: insights from the ARISTOTLE trial. Int J Cardiol. 2016;202:589–594. doi:10.1016/j.ijcard.2015.09.06226447668
   PubMed Web of Science ®Google Scholar
• BuchP, FribergJ, ScharlingH, et al. Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study. Eur Respir J. 2003;21(6):1012–1016. doi:10.1183/09031936.03.0005150212797497
   PubMed Web of Science ®Google Scholar
• ChahalH, Heckbert SR, Barr RG, et al. Ability of reduced lung function to predict development of atrial fibrillation in persons aged 45 to 84 years (from the Multi-Ethnic Study of Atherosclerosis-Lung Study). Am J Cardiol. 2015;115(12):1700–1704. doi:10.1016/j.amjcard.2015.03.01825900353
   PubMed Web of Science ®Google Scholar
• GoudisCA. Chronic obstructive pulmonary disease and atrial fibrillation: an unknown relationship. J Cardiol. 2017;69(5):699–705. doi:10.1016/j.jjcc.2016.12.01328188041
   PubMed Web of Science ®Google Scholar
• MatareseA, SarduC, ShuJ, et al. Why is chronic obstructive pulmonary disease linked to atrial fibrillation? A systematic overview of the underlying mechanisms. Int J Cardiol. 2019;276:149–151. doi:10.1016/j.ijcard.2018.10.07530446289
   PubMed Web of Science ®Google Scholar
• GamiAS, HodgeDO, HergesRM, et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol. 2007;49(5):565–571. doi:10.1016/j.jacc.2006.08.06017276180
   PubMed Web of Science ®Google Scholar
• KhalyfaA, GozalD. Connexins and atrial fibrillation in obstructive sleep apnea. Curr Sleep Med Rep. 2018;4(4):300–311. doi:10.1007/s40675-018-0130-731106116
   PubMedGoogle Scholar
• KentBD, MitchellPD, McNicholasWT. Hypoxemia in patients with COPD: cause, effects, and disease progression. Int J Chron Obstruct Pulmon Dis. 2011;6:199.21660297
   PubMed Web of Science ®Google Scholar
• BarberaJ, RocaJ, FerrerA, et al. Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease. Eur Respir J. 1997;10(6):1285–1291. doi:10.1183/09031936.97.100612859192930
   PubMed Web of Science ®Google Scholar
• HalpinDM, DecramerM, CelliB, et al. Risk of nonlower respiratory serious adverse events following COPD exacerbations in the 4-year UPLIFT® trial. Lung. 2011;189(4):261–268. doi:10.1007/s00408-011-9301-821678045
   PubMed Web of Science ®Google Scholar
• LiJ, AgarwalSK, AlonsoA, et al. Airflow obstruction, lung function, and incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 2014;129(9):971–980. doi:10.1161/CIRCULATIONAHA.113.00405024344084
   PubMed Web of Science ®Google Scholar
• LiaoK-M, ChenC-Y. Incidence and risk factors of atrial fibrillation in Asian COPD patients. Int J Chron Obstruct Pulmon Dis. 2017;12:2523. doi:10.2147/COPD.S14369128883719
   PubMed Web of Science ®Google Scholar
• TerzanoC, Romani S, Conti V, Paone G, Oriolo F, Vitarelli A. Atrial fibrillation in the acute, hypercapnic exacerbations of COPD. Eur Rev Med Pharmacol Sci. 2014;18(19):2908–2917.25339486
   PubMed Web of Science ®Google Scholar
• SidneyS, SorelM, QuesenberryCP, et al. COPD and incident cardiovascular disease hospitalizations and mortality: kaiser permanente medical care program. Chest. 2005;128(4):2068–2075. doi:10.1378/chest.128.4.206816236856
   PubMed Web of Science ®Google Scholar